Urinary Peptidomic Biomarkers in Kidney Diseases

In order to effectively develop personalized medicine for kidney diseases we urgently need to develop highly accurate biomarkers for use in the clinic, since current biomarkers of kidney damage (changes in serum creatinine and/or urine albumin excretion) apply to a later stage of disease, lack accur...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirolli, Vittorio, Pieroni, Luisa, Di Liberato, Lorenzo, Urbani, Andrea, Bonomini, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982248/
https://www.ncbi.nlm.nih.gov/pubmed/31877774
http://dx.doi.org/10.3390/ijms21010096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982248/
https://www.ncbi.nlm.nih.gov/pubmed/31877774
http://dx.doi.org/10.3390/ijms21010096

Ejemplares similares